猪链球菌2型JX分离株的生物学特性

从临床表现为脑膜炎、关节炎及败血症的发病猪分离到2株细菌，分别命名为JX02和JX03，经鉴定其形态、染色及培养特性均符合链球菌的特点，具α或β溶血，生化试验结果不稳定。用猪链球菌2型、1型和9型抗血清进行凝集试验，结果2株菌均能与猪链球2型抗血清凝集，其中1株菌对小鼠和家兔均有致病性，另1株菌只能致死家兔。PCR均能扩增2株菌的主要毒力因子基因。表明发病猪的病原不同于以往的C群链球菌，不是马链球菌兽疫亚种，而是属于R群的猪链球菌。     

Evaluation of Therapeutic Effect of Porcine β-defensin-2 on Streptococcus suis Infection

Defensin is a small cationic peptide widely distributed in animals and plants. It is an important component of the innate immune defense system of mammals. It has a broad spectrum of antibacterial, antiviral and antifungal activities. Porcine β-defensin-2 (PBD-2) is one of the natural defensins expressed in pigs and has good antibacterial activity in vitro. The purpose of this study is to evaluate the therapeutic effect of PBD-2 in the treatment of Streptococcus suis infection in animals and to provide more insights for evaluating the value of PBD-2 as a therapeutic drug. Firstly, the bactericidal activity of PBD-2 against S. suis clinical isolate SC-19 was measured in vitro, and the cytotoxicity of PBD-2 was tested on mouse-derived macrophages (RAW264.7). Subsequently, C57 female mice aged 4-6 weeks and weighing between 18-22 g infected with S. suis SC-19 were treated with PBD-2 or PBS (n ≥ 6). The survival rate of mice, and the bacteria loads, inflammatory cytokine levels, and pathological changes of tissues were determined. The results showed that PBD-2 (25-200 μg·mL^-1) could significantly inhibit the growth of S. suis SC-19 in a concentration-dependent manner (P<0.05). At the same time, PBD-2 had no significant toxic effect on RAW cells (P>0.05). The in vivo study revealed that PBD-2 treatment could effectively reduce the mortality of mice infected with S. suis SC-19. At the same time, PBD-2 treatment significantly reduced bacteria loads in brain, lung, spleen and blood of mice, and decreased the levels of inflammatory cytokines IL-6, IL-12 and TNF-α in mouse sera (P<0.05). At the same time, PBD-2 treatment also significantly alleviated the degree of pathological damages in lung and spleen tissues of mice infected with bacteria (P<0.05). These results indicate that PBD-2 confers great resilience to S. suis in vitro without significant cytotoxicity, while it also exhibits a therapeutic effect on S. suis infection in mice, suggesting that the use of PBD-2 as a therapeutic drug and substitutes for antibiotics is of an excellent prospect.     

Acquired antimicrobial resistance in the intestinal microbiota of diverse cat populations

The aim of this study was to investigate the prevalence of acquired antimicrobial resistance in the resident intestinal microbiota of cats and to identify significant differences between various cat populations. Escherichia coli, Enterococcus faecalis, E. faecium and Streptococcus canis were isolated as faecal indicator bacteria from rectal swabs of 47 individually owned cats, 47 cattery cats and 18 hospitalised cats, and submitted through antimicrobial sensitivity tests. The results revealed that bacteria isolated from hospitalised and/or cattery cats were more frequently resistant than those from individually owned cats. E. coli isolates from hospitalised cats were particularly resistant to ampicillin, tetracycline and sulfonamide. Both enterococci and streptococci showed high resistance to tetracycline and in somewhat lesser extent to erythromycin and tylosin. Most E. faecium isolates were resistant to lincomycin and penicillin. One E. faecalis as well as one E. faecium isolate from hospitalised cats showed 'high-level resistance' (MIC > 500 microg/ml) against gentamicin, a commonly used antimicrobial agent in case of human enterococcal infections. The results of this research demonstrate that the extent of acquired antimicrobial resistance in the intestinal microbiota of cats depends on the social environment of the investigated population. It is obvious that the flora of healthy cats may act as a reservoir of resistance genes.     

仔猪多发性关节炎病原菌的分离鉴定及耐药性研究

从山东地区32个猪场发生多发性关节炎的仔猪体内分离到15株病原菌。通过对分离菌株的形态染色、分离培养、生化试验及种特异性基因的PCR扩增等方法鉴定菌株,结果显示4株分离菌株为副猪嗜血杆菌,7株为猪链球菌,2株为化脓隐秘杆菌,1株为猪胸膜肺炎放线杆菌,1株为猪丹毒杆菌。15株分离菌均对昆明小鼠有较强的致病力,且对先锋霉素类抗生素高度敏感,大多数菌株还对青霉素类、头孢菌素Ⅲ类、氟喹诺酮类、万古霉素、壮观霉素等抗生素高度敏感。该试验表明山东地区猪场仔猪多发性关节炎的病原菌主要是副猪嗜血杆菌和猪链球菌,可交替使用上述敏感抗生素防治该病。     

固定化唾液链球菌的酶学性质研究

以海藻酸钙为载体包埋唾液链球菌嗜热亚种Y-2的菌体细胞,对固定化细胞催化合成γ-氨基丁酸进行了较详细的研究。研究结果表明:固定化细胞谷氨酸脱羧酶(Glutamate decarboxylase,GAD)反应的最适温度为40℃,同时具有良好的温度稳定性。固定化细胞酶活最适反应pH为3.8。细胞经固定化后pH稳定性明显增加,GAD酶活回收率普遍高于游离细胞。0.1%Triton X-100具有较强的酶活促进作用。固定化细胞的GAD在酶促反应中并不存在底物抑制现象。在上述最优条件下进行菌体生产力测试,固定化细胞转化L-谷氨酸单钠盐11 h后,转化液γ-氨基丁酸的浓度达到了2.79 g/L。     

猪链球菌病病原的分离鉴定及药敏试验

采集疑似猪链球菌病的病猪病料,经病原分离培养、生化鉴定、动物试验和药教试验,结果表明所分离的细菌为α溶血链球菌(α-hemolytic streptococci.),该菌对霸王金针、利福平、沙拉噻呋极敏,对替米考星、头孢唑啉钠、氨苄西林钠、猪康2号为高敏.     

广东省某猪场链球菌的分离与鉴定

为了解广东省茂名某猪场暴发猪链球菌病的详细情况及制作灭活疫苗给猪群接种免疫。该研究通过分离细菌、PCR鉴定、生化试验等方法分离、鉴定细菌,并通过动物试验了解该分离菌的致病性。最后通过药敏试验找出高敏药物用于临床治疗及了解该猪场细菌病的耐药性,指导临床合理用药。     

表观健康猪群携带猪链球菌2型毒力因子的分布特征

为了研究钦州市猪链球菌2型(SS2)的毒力因子分布特征,采用多重PCR方法对从我市健康猪扁桃体分离的11株SS2相关毒力基因——荚膜多糖(Cps2J),溶菌酶释放蛋白(Mrp),胞外蛋白因子(EF),溶血素(Sly),进行毒力基因检测。检测结果显示:毒力基因型为Mrp+epf+Sly+共有8株,毒力基因型为Mrp+epf+Sly-共有1株,这两种毒力基因型可归为强毒力基因型,占此次健康猪源毒株的81.8%;另外Mrp-epf-Sly-共有2株,属于弱毒和无毒基因型,占健康猪源毒株的18.2%。通过结果分析,预示我市目前SS2的主要流行菌株是同时具有4种毒力因子的高致病性菌株。     

猪链球菌2型毒力因子研究进展

猪链球菌2型(SS2)是一种重要的人兽共患病病原菌,其主要毒力因子包括荚膜多糖、溶菌酶释放蛋白、溶血素、纤连蛋白结合蛋白、谷氨酸脱氢酶等,但是这些经典的毒力因子不足以解释猪链球菌病发病的临床症状,而且毒力表型往往与实际毒力及临床症状不符。近年来随着研究的深入,鉴定出一系列毒力相关元件,主要有Sao蛋白、存在于89K毒力岛的双信号转导系统(salk-salR)、dltA基因、pgdA基因、srtA基因、Ⅳ型二肽基肽酶(dipeptidyl peptidaseⅣ,DPPⅣ)、毒力调控子R(control of virulence R,CovR)、烯醇酶(enolase)、谷氨酰胺合成酶(glutamine synthetase,GlnA)等。论文对以上毒力因子研究进展进行综述,以期为SS2毒力因子及致病机制研究提供参考。